Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:09 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:09 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:09 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:08 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:08 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:08 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:09 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...